ACAD vs EMR · P/E 15, rev $576.0M vs P/E 34, rev $4.86B
ACADIA Pharmaceuticals Inc (ACAD) versus Emerson Electric Company (EMR) — a side-by-side from cached financials, not a winner call.
ACADIA Pharmaceuticals Inc (ACAD) is a biotechnology company listed on US.
Emerson Electric Company (EMR) is a specialty industrial machinery company listed on NYSE.
Latest reported ACAD revenue for 2026-06-30 was $576.0M. Net income was $35.1M. ACAD currently screens at market cap $3.51B and trailing P/E 15.3.
Latest reported EMR revenue for 2025-09-30 was $4.86B. Net income was $2.25B. Revenue was up 6.6% from 2025-06-30 to 2025-09-30. EMR currently screens at market cap $83.45B and trailing P/E 34.5.
ACAD currently screens at market cap $3.51B and trailing P/E 15.3. EMR currently screens at market cap $83.45B and trailing P/E 34.5.
Not investment advice. Open the ACAD and EMR stock pages for the full models.
Not investment advice.